Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.
Open | $1.560 |
Close | $1.450 |
Volume / Avg. | 124.494K / 195.316K |
Day Range | 1.440 - 1.619 |
52 Wk Range | 0.980 - 4.190 |
Market Cap | $71.106M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 3.79% |
Days to Cover | 5.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corvus Pharma (NASDAQ: CRVS) through any online brokerage.
Other companies in Corvus Pharma’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Aligos Therapeutics (NASDAQ:ALGS) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for Corvus Pharma (NASDAQ: CRVS) was reported by Cantor Fitzgerald on Monday, April 1, 2024. The analyst firm set a price target for 0.00 expecting CRVS to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Corvus Pharma (NASDAQ: CRVS) is $1.45 last updated April 26, 2024 at 6:44 PM EDT.
There are no upcoming dividends for Corvus Pharma.
Corvus Pharma’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Corvus Pharma.
Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.